| Literature DB >> 27078815 |
Wei-Wen Hsu1, David Todem2, KyungMann Kim3.
Abstract
The evaluation of cure fractions in oncology research under the well known cure rate model has attracted considerable attention in the literature, but most of the existing testing procedures have relied on restrictive assumptions. A common assumption has been to restrict the cure fraction to a constant under alternatives to homogeneity, thereby neglecting any information from covariates. This article extends the literature by developing a score-based statistic that incorporates covariate information to detect cure fractions, with the existing testing procedure serving as a special case. A complication of this extension, however, is that the implied hypotheses are not typical and standard regularity conditions to conduct the test may not even hold. Using empirical processes arguments, we construct a sup-score test statistic for cure fractions and establish its limiting null distribution as a functional of mixtures of chi-square processes. In practice, we suggest a simple resampling procedure to approximate this limiting distribution. Our simulation results show that the proposed test can greatly improve efficiency over tests that neglect the heterogeneity of the cure fraction under the alternative. The practical utility of the methodology is illustrated using ovarian cancer survival data with long-term follow-up from the surveillance, epidemiology, and end results registry.Entities:
Keywords: Cure rate model; Goodness-of-fit; Likelihood ratio; Ovarian cancer; SEER registry; Score functions; Sensitivity analysis; Unidentified parameters
Mesh:
Year: 2016 PMID: 27078815 PMCID: PMC8314275 DOI: 10.1111/biom.12514
Source DB: PubMed Journal: Biometrics ISSN: 0006-341X Impact factor: 2.571